Interestingly, patients with HCC and high CD28+PD-1+ Tc-cell enrichment demonstrated increased sensitivity to common chemotherapy agents, such as vinorelbine, bortezomib, and docetaxel. The gene discussed is CD28; the disease is hepatocellular carcinoma.